Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus
Hao Li, Yang-Xin Fu, Qi Wu, Yong Zhou, David K. Crossman, PingAr Yang, Jun Li, Bao Luo, Laurence M. Morel, Janusz H. Kabarowski, Hideo Yagita, Carl F. Ware, Hui-Chen Hsu, John D. Mountz
Hao Li, Yang-Xin Fu, Qi Wu, Yong Zhou, David K. Crossman, PingAr Yang, Jun Li, Bao Luo, Laurence M. Morel, Janusz H. Kabarowski, Hideo Yagita, Carl F. Ware, Hui-Chen Hsu, John D. Mountz
View: Text | PDF
Research Article Autoimmunity Immunology

Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus

  • Text
  • PDF
Abstract

Systemic lupus erythematosus (SLE) is a severe autoimmune disease that is associated with increased circulating apoptotic cell autoantigens (AC-Ags) as well as increased type I IFN signaling. Here, we describe a pathogenic mechanism in which follicular translocation of marginal zone (MZ) B cells in the spleens of BXD2 lupus mice disrupts marginal zone macrophages (MZMs), which normally clear AC debris and prevent follicular entry of AC-Ags. Phagocytosis of ACs by splenic MZMs required the megakaryoblastic leukemia 1 (MKL1) transcriptional coactivator–mediated mechanosensing pathway, which was maintained by MZ B cells through expression of membrane lymphotoxin-α1β2 (mLT). Specifically, type I IFN–induced follicular shuttling of mLT-expressing MZ B cells disengaged interactions between these MZ B cells and LTβ receptor–expressing MZMs, thereby downregulating MKL1 in MZMs. Loss of MKL1 expression in MZMs led to defective F-actin polymerization, inability to clear ACs, and, eventually, MZM dissipation. Aggregation of plasmacytoid DCs in the splenic perifollicular region, follicular translocation of MZ B cells, and loss of MKL1 and MZMs were also observed in an additional murine lupus model and in the spleens of patients with SLE. Collectively, the results suggest that lupus might be interrupted by strategies that maintain or enhance mechanosensing signaling in the MZM barrier to prevent follicular entry of AC-Ags.

Authors

Hao Li, Yang-Xin Fu, Qi Wu, Yong Zhou, David K. Crossman, PingAr Yang, Jun Li, Bao Luo, Laurence M. Morel, Janusz H. Kabarowski, Hideo Yagita, Carl F. Ware, Hui-Chen Hsu, John D. Mountz

×

Figure 2

Type I IFN indirectly promotes dissipation of spleen MZMs via follicular translocation of mLT+ B cells.

Options: View larger image (or click on image) Download as PowerPoint
Type I IFN indirectly promotes dissipation of spleen MZMs via follicular...
(A–C) Mixed BM chimeric mice were generated by reconstitution with 1:1 GFP+ Ifnar+/+ plus GFP– Ifnar–/– BM cells into BXD2-Rag1–/– mice (5-month-old) and analyzed 4 months later. (A) FACS analysis of the percentage of MZMs (F4/80negCD11bloSIGN-R1+I-Ab–) derived from GFP+ Ifnar+/+ and GFP– Ifnar–/– donors. (B) Confocal microscopic images show the distribution of transferred donor cells. Original magnification, ×20; boxed areas in the left panel were digitally magnified and are shown in the right 2 panels (white arrows point to GFP–IgM+IFNAR– red B cells). MS, marginal sinus. (C) Quantitation of the distribution of GFP+ and GFP– donor cells in either follicles or the MZ of the recipient spleens (χ2 test). Five randomly chosen areas were counted for each follicle. (D) FACS analysis of mLT expression on follicles (IgMloCD21loCD23hi), MZ (IgMhiCD21hiCD23lo), and MZ-P (IgMhiCD21hiCD23hi) CD19+ B cells from the indicated mouse strains. (E) Confocal microscopic images show the location of mLT+CD1d+ B cells (yellow) in spleens from the indicated mouse strains. Original magnification, ×20; digitally magnified views of the boxed areas in the top panels are shown in the bottom panels. (F) Quantitation of the distribution ratio of mLT+CD1d+ B cells that were either in the follicles or the MZ (χ2 test). (G) Fluorescence microscopic images of MARCO+ MZMs in 2-month-old B6 and B6-Ltbfl/fl Cd19-Cre mouse spleens (original magnification, ×4). (H) FACS quantitation of the percentage of MZMs (F4/80negCD11bloSIGN-R1+I-Ab–) in spleens from the indicated mouse strains. Data represent the mean ± SEM (§P < 0.005 vs. control B6, Student’s t test). Results in D–H were derived from 4- to 6-month-old mice; n = 4–6 mice per group. FO, follicles.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts